Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson’s Disease
ACS Omega · 21.02.2023 · 8 (7) · 6825-6837
DOI: 10.1021/acsomega.2c07521 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 10.02.2023. Verfasst von Prabitha Prabhakaran und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570 015, Karnataka, India. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570 015, Karnataka, India.
- Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570 015, Karnataka, India.
- Spice and Flavour Science Department, CSIR-Central Food Technological Research Institute, Mysore 570 020, Karnataka, India.
- Department of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru 560 078, Karnataka, India.
ORCID-Profile: Nulgumnalli Manjunathaiah Raghavendra, Prashantha Kumar Br
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Prabhakaran, P., Nadig, A., M, S., Tuladhar, S., Raju, R. M., Chidambaram, S. B., Kempaiah, B. B., Raghavendra, N. M., & Kumar Br, P. (2023). Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson’s Disease. ACS Omega, 8(7), 6825-6837. https://doi.org/10.1021/acsomega.2c07521
Vancouver
Prabhakaran P, Nadig A, M S, Tuladhar S, Raju RM, Chidambaram SB, et al. Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson’s Disease. ACS Omega. 2023;8(7):6825-6837. doi:10.1021/acsomega.2c07521
BibTeX
@article{Prabhakaran2023,
author = {Prabhakaran, Prabitha and Nadig, Abhishek and M, Sahyadri and Tuladhar, Sunanda and Raju, Ruby Mariam and Chidambaram, Saravana Babu and Kempaiah, Bettadaiah Bheemanakere and Raghavendra, Nulgumnalli Manjunathaiah and Kumar Br, Prashantha},
title = {Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson’s Disease},
journal = {ACS Omega},
year = {2023},
volume = {8},
number = {7},
pages = {6825--6837},
doi = {10.1021/acsomega.2c07521}
}
EUVIMED